
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.180 | 0.180 | 0.000 |
Stocks | 99.820 | 99.820 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.278 | 15.940 |
Price to Book | 1.837 | 1.897 |
Price to Sales | 1.870 | 1.482 |
Price to Cash Flow | 9.759 | 9.612 |
Dividend Yield | 2.766 | 3.157 |
5 Years Earnings Growth | 8.803 | 12.452 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 31.380 | 27.652 |
Industrials | 29.900 | 29.064 |
Financial Services | 16.210 | 17.849 |
Basic Materials | 7.870 | 4.998 |
Consumer Defensive | 6.000 | 6.909 |
Consumer Cyclical | 5.780 | 6.302 |
Utilities | 2.870 | 3.937 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
DSV | DK0060079531 | 14.26 | 1,113.5 | -1.11% | |
Novo Nordisk B | DK0062498333 | 11.98 | 427.7 | -1.46% | |
Danske Bank | DK0010274414 | 8.87 | 195.1 | +0.41% | |
Novozymes B | DK0060336014 | 7.85 | 381.4 | +0.32% | |
Coloplast | DK0060448595 | 6.57 | 672.8 | -1.12% | |
Vestas Wind | DK0061539921 | 5.86 | 87.9 | +1.97% | |
Pandora | DK0060252690 | 5.77 | 870.0 | -3.78% | |
Genmab | DK0010272202 | 5.72 | 1,240.0 | +0.49% | |
Carlsberg B | DK0010181759 | 4.66 | 827.0 | +0.63% | |
Tryg | DK0060636678 | 3.00 | 145.7 | +0.62% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LI Aktier Globale Indeks | 5.08B | 0.89 | 15.10 | 9.95 | ||
LI Aktier Globale III | 9.59M | 16.60 | 2.38 | - | ||
LI Aktier Globale II | 9.76M | -0.79 | 9.93 | 8.38 | ||
LI Aktier Globale | 10.92M | -0.34 | 8.12 | 9.57 | ||
LI Aktier Europa | 5.34M | 1.72 | 11.15 | 8.00 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review